Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals insights into canine hypoadrenocorticism
"Clinicians should always use method-specific thresholds and, if these are not available, then they should exercise greater caution in their interpretation.”

Researchers identify differences in electrolyte measurements between point-of-care and reference analysers.

Researchers at the University of Glasgow have revealed inherent differences between the electrolyte concentrations measured by point-of-care analysers and reference laboratory methods in dogs with hypoadrenocorticism.

Canine hypoadrenocorticism - also known as Addison's disease - is a rare, life-threatening condition caused when adrenal glands fail to produce enough hormones for normal body function.

The study, published in the Journal of Small Animal Practice, investigated the performance of two point-of-care analysers (IDEXX Catalyst Dx and IDEXX VetStat) against a reference laboratory method for the measurement of blood sodium, potassium and chloride concentrations. It also looked at sodium-to-potassium ratios in dogs diagnosed with hypoadrenocorticism.

Some 48 dogs with hypoadrenocorticism were enrolled in the study, in which a total of 329 paired samples were measured on the Catalyst analyser and by the ion-selective electrode (ISE). Researchers tested another 72 paired samples on both the VetStat analyser and by ISE.

Sam Fowlie, a corresponding author for the paper, said: “Our results indicate that the sodium, potassium and therefore the sodium-to-potassium ratios, as well as the chloride concentrations measured by the Catalyst and VetStat analysers, may not be used interchangeably with those from a reference laboratory analyser using an indirect ISE method.

"Both analysers tended to give higher results than the reference method for all analytes, except for potassium when measured on the VetStat.”

The clinical effects of any difference in the electrolyte results were also investigated. For the Catalyst, there were 21 cases with discordant sodium results, 27 cases with discordant potassium results and 46 cases with discordant chloride results. The VetStat meanwhile produced results which disagreed with the ISE method in 19 cases for sodium, three cases for potassium measurement and nine cases for chloride analysis.

JSAP editor Nicola Di Girolamo, said: “This study reveals significant systematic differences (“bias”) between the three analysers in this study. Comparing numerical results from different analytical methods – be they point-of-care or reference laboratories – can be dangerous for patients.

"Clinicians should always use method-specific thresholds and, if these are not available (for example the sodium-to-potassium ratios on some analysers), then they should exercise greater caution in their interpretation.”

Image (C) Ian Ramsey.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.